<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04567043</url>
  </required_header>
  <id_info>
    <org_study_id>00078615.2</org_study_id>
    <nct_id>NCT04567043</nct_id>
  </id_info>
  <brief_title>Treating Opioid Misuse Via Mindfulness-Based Just-in-Time Adaptive Intervention</brief_title>
  <acronym>MORE-JITAI</acronym>
  <official_title>Reating Opioid Misuse Via Mindfulness-Based Just-in-Time Adaptive Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot RCT will examine the preliminary efficacy of a telehealth version of&#xD;
      Mindfulness-Oriented Recovery Enhancement (MORE) enriched with a smartphone-based&#xD;
      just-in-time adaptive intervention (JITAI) for patients with chronic pain on long-term opioid&#xD;
      therapy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 24, 2020</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in momentary craving</measure>
    <time_frame>Baseline through 1-month follow-up</time_frame>
    <description>Craving measured by numeric rating scale via ecological momentary assessments (min 0, max 10, with higher scores meaning more craving)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in momentary pain: numeric rating scale</measure>
    <time_frame>Baseline through 1-month follow-up</time_frame>
    <description>Pain measured by numeric rating scale via ecological momentary assessments (min 0, max 10, with higher scores meaning more pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in momentary positive affect</measure>
    <time_frame>Baseline through 1-month follow-up</time_frame>
    <description>Positive affect measured by numeric rating scale via ecological momentary assessments (min 0, max 10, with higher scores meaning more positive affect)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in momentary stress</measure>
    <time_frame>Baseline through 1-month follow-up</time_frame>
    <description>Stress measured by numeric rating scale via ecological momentary assessments (min 0, max 10, with higher scores meaning more stress)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in heart rate variability</measure>
    <time_frame>Baseline through 1-month follow-up</time_frame>
    <description>Changes in heart rate variability (HRV) measured via ambulatory HRV assessment</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in opioid misuse</measure>
    <time_frame>Baseline through post-treatment (week 8)</time_frame>
    <description>Scores on Current Opioid Misuse Measure, with higher scores indicating higher opioid misuse (min 0, max 68)</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in chronic pain symptoms</measure>
    <time_frame>Baseline through post-treatment (week 8)</time_frame>
    <description>Scores on Brief Pain Inventory, with higher scores indicating higher pain severity (min 0, max 10)</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in opioid dose</measure>
    <time_frame>Baseline through post-treatment (week 8)</time_frame>
    <description>Opioid dose as assessed with Timeline Followback Procedure</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in self-transcendence</measure>
    <time_frame>Baseline through post-treatment (week 8)</time_frame>
    <description>Self-transcendence measured by Nondual Awareness Dimensional Assessment, with higher scores indicating higher self-transcendence (min 13, max 65)</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in mindful reinterpretation of pain sensations</measure>
    <time_frame>Baseline through post-treatment (week 8)</time_frame>
    <description>Mindful reinterpretation of pain sensations measured by the Mindful Reinterpretation of Pain Sensations Scale, with higher scores indicating higher reinterpretation of pain sensations (min 0, max 45)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Mindfulness-Oriented Recovery Enhancement+JITAI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will attend a telehealth Mindfulness-Oriented Recovery Enhancement (MORE) group plus mindfulness JITAI weekly for eight weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supportive Psychotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will attend a telehealth supportive psychotherapy group weekly for eight weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>MORE+JITAI</intervention_name>
    <description>Mindfulness-Oriented Recovery Enhancement (MORE) is a group behavioral intervention that unites mindfulness training, cognitive reappraisal, and positive psychological principles into an integrative intervention strategy targeting mechanisms of pain and opioid misuse. JITAI involves stress-triggered reminders to practice mindfulness skills.</description>
    <arm_group_label>Mindfulness-Oriented Recovery Enhancement+JITAI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Supporive Psychotherapy</intervention_name>
    <description>A supportive psychotherapy group will allow participants to express emotions, share experiences, and receive social support under the guidance of a skilled therapist.</description>
    <arm_group_label>Supportive Psychotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Current chronic pain diagnosis determined by physician assessment (including but not&#xD;
             limited to ICD-9 diagnoses 338.0, 338.21, 338.22, 338.28, 338.29, 338.4)&#xD;
&#xD;
          -  Current use of prescription opioid agonist or mixed agonist-antagonist analgesics for&#xD;
             &gt;90 days&#xD;
&#xD;
          -  Willingness to participate in study interventions and assessments&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior experience with Mindfulness-Based Stress Reduction, Mindfulness-Based Cognitive&#xD;
             Therapy, or Mindfulness-Based Relapse Prevention&#xD;
&#xD;
          -  Active suicidality, schizophrenia, psychotic disorder&#xD;
&#xD;
          -  Presence of clinically unstable systemic illness judged to interfere with treatment&#xD;
&#xD;
          -  No access to internet (which will prevent telehealth-based treatment)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eric L Garland</last_name>
    <phone>801-581-3826</phone>
    <email>eric.garland@socwk.utah.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Center on Mindfulness and Integrative Health Intervention Development</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Garland</last_name>
      <phone>801-581-3826</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Garland EL, Manusov EG, Froeliger B, Kelly A, Williams JM, Howard MO. Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial. J Consult Clin Psychol. 2014 Jun;82(3):448-459. doi: 10.1037/a0035798. Epub 2014 Feb 3.</citation>
    <PMID>24491075</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 22, 2020</study_first_submitted>
  <study_first_submitted_qc>September 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2020</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Utah</investigator_affiliation>
    <investigator_full_name>Eric Garland</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Opioid-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

